Biodiversity
"The decision to form the National Biodiversity Board is welcome. It has long been a demand for the protection of medicinal plants in the country. The government has also announced the setting up of a New Vaccines Board, which would promote research and development in the field of new drugs. I do not think that the tax incentives for pharmaceutical research and development are a real attraction for companies. Even last year, the government had announced a similar scheme. But it was not of much help. The process of availing such incentives is very cumbersome. And the government has not yet come out with full details as to what type of facilities they would provide to companies.'
Related Content
- State of global environmental governance 2023
- Global resources outlook 2024
- Malawi economic monitor, February 2024
- Effective, inclusive and sustainable multilateral actions to tackle climate change, biodiversity loss and pollution
- Measures to enhance forest conservation and reduce deforestation: viewpoints and lessons from producing countries
- State of the world’s migratory species